Glutaraldehyde erythropoietin protects kidney in ischaemia/reperfusion injury without increasing red blood cell production

BACKGROUND AND PURPOSE: Recombinant human erythropoietin (rHuEPO) is currently the mainstay of renal anaemia treatment. Recently, rHuEPO has been shown to provide pleiotrophic tissue protection in various pathological conditions. However, the benefits of rHuEPO beyond anaemia treatment are limited b...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Chattong, S, Tanamai, J, Kiatsomchai, P, Nakatsu, M, Sereemaspun, A, Pimpha, N, Praditpornsilpa, K, Rojanathanes, R, Sethpakadee, A, Tungsanga, K, Eiam-Ong, S, Manotham, K
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2013
Matèries:
Research Papers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3570014/
https://ncbi.nlm.nih.gov/pubmed/22861820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1476-5381.2012.02123.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars